Piramal Pharma Limited at its board meeting held on May 10, 2024, recommended a final dividend of INR 0.11 per Equity Share of INR 10 each for the financial year ended 31 March 2024, which will be paid /dispatched after the 4th Annual General Meeting, subject to the approval of shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.6 INR | -1.27% | -1.47% | +6.34% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.34% | 2.38B | |
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024